Author: Sebastian HeldPublisher: BoD – Books on Demand
ISBN: 3936863164
Category :
Languages : en
Pages : 162
Book Description
Impact of Big Pharma Organizational Structure on R&D Productivity
Author: Sebastian HeldPublisher: BoD – Books on Demand
ISBN: 3936863164
Category :
Languages : en
Pages : 162
Book Description
Official Gazette of the United States Patent and Trademark Office
Author: Annual Report of the Commissioner of Patents
Author: United States. Patent OfficePublisher:
ISBN:
Category : Agriculture
Languages : en
Pages : 1504
Book Description
Prior to 1862, when the Department of Agriculture was established, the report on agriculture was prepared and published by the Commissioner of Patents, and forms volume or part of volume, of his annual reports, the first being that of 1840. Cf. Checklist of public documents ... Washington, 1895, p. 148.
XARELTO Drug Profile, 2023
Author: DrugPatentWatchPublisher: DrugPatentWatch.com
ISBN: 1934899321
Category : Medical
Languages : en
Pages : 580
Book Description
XARELTO Drug Profile, 2023
This report focuses on XARELTO and covers the following critical aspects of this drug:
- United States patents
- Expired United States patents
- FDA Paragraph IV patent challenges
- District Court patent litigation
- Patent Trial and Appeal Board (PTAB) patent cases
- European supplementary protection certificates (SPCs)
- Clinical trials
- Drug prices
- Annual sales revenues
- Finished product suppliers
- Raw active pharmaceutical ingredient (API) sources
NAMZARIC Drug Profile, 2023
Author: DrugPatentWatchPublisher: DrugPatentWatch.com
ISBN: 1934899704
Category : Medical
Languages : en
Pages : 114
Book Description
NAMZARIC Drug Profile, 2023
This report focuses on NAMZARIC and covers the following critical aspects of this drug:
- United States patents
- Expired United States patents
- FDA Paragraph IV patent challenges
- District Court patent litigation
- Patent Trial and Appeal Board (PTAB) patent cases
- European supplementary protection certificates (SPCs)
- Clinical trials
- Drug prices
- Finished product suppliers
- Raw active pharmaceutical ingredient (API) sources
NUCYNTA ER Drug Profile, 2023
Author: DrugPatentWatchPublisher: DrugPatentWatch.com
ISBN: 1934899631
Category : Medical
Languages : en
Pages : 153
Book Description
NUCYNTA ER Drug Profile, 2023
This report focuses on NUCYNTA ER and covers the following critical aspects of this drug:
- United States patents
- Expired United States patents
- FDA Paragraph IV patent challenges
- District Court patent litigation
- Patent Trial and Appeal Board (PTAB) patent cases
- European supplementary protection certificates (SPCs)
- Clinical trials
- Drug prices
- Finished product suppliers
- Raw active pharmaceutical ingredient (API) sources
European Dental Guide
Author: Publisher:
ISBN:
Category : Dental instruments and apparatus
Languages : en
Pages : 220
Book Description
Masterpieces of Swiss Entrepreneurship
Author: Jean-Pierre JeannetPublisher: Springer Nature
ISBN: 3030652874
Category : Business & Economics
Languages : en
Pages : 579
Book Description
This open access book focuses on Switzerland-based medium-sized companies with a longstanding export tradition and a proven dominance in global niche markets. Based upon in-depth documentation and analysis of 36 Swiss companies over their entire history, an expert team of authors presents several parallels in the pathways and success factors which allowed these firms to become dominant and operate from a high-cost location such as Switzerland. The book enhances these insights by providing detailed company profiles documenting the company history, development, and how their relevant global niche positions were reached. Readers will benefit from these profiles as they compile a diverse selection of industries, mainly active within the B2B sector, with mostly mature companies (60 years to older than 100 years since founding) and different types of ownership structures including family firms. ‘Masterpieces of Swiss Entrepreneurship’ brings unique learning opportunities to owners and leaders of SMEs in Switzerland and elsewhere. Findings are based on detailed bottom-up research of 36 companies -- without any preconceived notions. The book is both conceptual and practical. It fosters understanding for different choices in development pathways and management practices. Matti Alahuhta, Chairman DevCo Partners, ex-CEO Kone, Board member of several global listed companies, Helsinki, Finland Start-up entrepreneurs need proven models from industry which demonstrate the various paths to success. “Masterpieces of Swiss Entrepreneurship” provides deep insights highlighting these models and the important trade-offs entrepreneurial teams must consider when choosing the path of high growth or of maximum control, as they are often mutually exclusive. Gina Domanig, Managing Partner, Emerald Technology Ventures, Zurich
European Collaboration: Towards Drug Developement and Rational Drug Therapy
Author: F.C. TulunayPublisher: Springer Science & Business Media
ISBN: 3642554547
Category : Medical
Languages : en
Pages : 180
Book Description
“European Collaboration: Towards Drug Development and Rational Drug Therapy “ is the title of the 6th Congress of the European Association for Clinical Pharmacology and Therapeutics ( EACPT )being held in Istanbul,Turkey from June 24th -28th 2003. Istanbul has been chosen as the venue for this congress as a unique city bridging two continents and bringing together scientists from a large number of countries. This volume has been edited by Prof Cankat Tulunay ( the President of the Congress ) and Prof Michael Orme ( co-ordinator of the Scientific Committee and Hon. Secretary of EACPT. The volume contains details of the 21 symposia and 3 workshops that are taking place in Istanbul together with the abstracts from the more than 400 submitted and being presented in Istanbul. The organisers hope that you will enjoy both the scientific and cultural aspects of this Congress. Table of contents Abstracts of lectures 1 Table of abstracts 39 Abstracts 69 Abstracts of lectures 23 June 2003 Whole Day Course indeed it is important to stress that this process in Introduction to the Methodology of Clinical Trials a continuum, with useful information coming from different departments contributing day by Paola Antonini day to the final product profile. Key areas of Pre- Medical Affairs Director, Merck Sharp & Dohme clinical Development are Pharmacology, Toxicol- Italy ogy, Pharmacokinetics and Chemistry and Ph- macy.
Author: